1. Home
  2. MFA vs NEO Comparison

MFA vs NEO Comparison

Compare MFA & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.59

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.37

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
NEO
Founded
1997
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MFA
NEO
Price
$9.59
$8.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$11.05
$13.38
AVG Volume (30 Days)
1.5M
2.2M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
14.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
$10.02
$9.73
P/E Ratio
$7.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.78
$4.72
52 Week High
$10.57
$13.74

Technical Indicators

Market Signals
Indicator
MFA
NEO
Relative Strength Index (RSI) 42.10 46.15
Support Level $9.38 $7.50
Resistance Level $9.79 $8.84
Average True Range (ATR) 0.21 0.57
MACD -0.07 -0.05
Stochastic Oscillator 14.87 9.74

Price Performance

Historical Comparison
MFA
NEO

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: